This announcement is a separate document:
大参林医药集团股份有限公司关于董事会秘书辞职暨指定财务总监代行董事会秘书职责的公告
Announcement from Dashenlin Pharmaceutical Group on the resignation of the board secretary and appointment of the CFO as acting board secretary.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.